Breadcrumb

YOUR SUPPORT MADE SO MUCH POSSIBLE THIS YEAR!
YOUR SUPPORT MADE SO MUCH POSSIBLE THIS YEAR!
BUSINESS DEVELOPMENT AND RESEARCH TRAINING ACTIVITIES
BUSINESS DEVELOPMENT AND RESEARCH TRAINING ACTIVITIES
RI-MUHC ANNUAL REPORT 2022YEAR IN REVIEWCHILD HEALTH AND HUMAN DEVELOPMENT (CHHD) PROGRAMRESEARCH HIGHLIGHTSNext-generation sequencing and...
Selected highlights from our research programs:
Selected highlights from our research programs:
YEAR IN REVIEW: PROGRAMS AND PUBLICATIONS 2021–2022
YEAR IN REVIEW: PROGRAMS AND PUBLICATIONS 2022–2023
Purpose is to understand post-COVID symptom evolution and impact on patients’ lives
RI-MUHC ANNUAL REPORT 2022YEAR IN REVIEWINJURY REPAIR RECOVERY (IRR) PROGRAMRESEARCH HIGHLIGHTSThe Clinical Innovation Platform opens at...
CAMCCO-L is the first Canadian platform for interdisciplinary training in perinatal research on medications...
RI-MUHC ANNUAL REPORT 2022YEAR IN REVIEWCARDIOVASCULAR HEALTH ACROSS THE LIFESPAN (CHAL) PROGRAMRESEARCH HIGHLIGHTSLifespan perspective on...
The RI-MUHC scientist will join 55 experts from more than 30 countries working jointly to study fatty liver...
RI-MUHC ANNUAL REPORT 2022FUNDING SUMMARY AND WORLDWIDE NETWORKWe are proud of our researchers’ success in funding competitions and...
McGill startup is developing an innovative mixed reality platform to support surgeons
The newly created EArly and mid-CAreer REsearchers network (EACARE) will promote networking...
Honours and awards published August 2022 – July 2023
Monthly seminars, 12 to 1 p.m.
CHAL Program Seminar Series Fall 2022
RI-MUHC ANNUAL REPORT 2022AWARDS AND RECOGNITIONMichal AbrahamowiczFirst Canadian to receive Honorary Lifetime Member award, International...
RI-MUHC ANNUAL REPORT 2022AWARDS AND RECOGNITIONMichal AbrahamowiczFirst Canadian to receive Honorary Lifetime Member award, International...
RI-MUHC ANNUAL REPORT 2022FOCUS ON OUR TRAINEESWhat is our new generation of researchers achieving today? Over 1,400 research trainees play...
RI-MUHC ANNUAL REPORT 2022THE RI-MUHC IN NUMBERS: 2021-2022 500active members,including fundamental,clinical and evaluativeresearchers...